期刊文献+

HPLC法测定雷贝拉唑钠肠溶片的含量和有关物质 被引量:8

Determination of rabeprazole in Rabeprazole Sodium Enteric-coated Tablets and its related substances by HPLC
下载PDF
导出
摘要 目的建立高效液相色谱法,测定雷贝拉唑钠肠溶片的含量及有关物质。方法采用ZORBAX SB-C18(4.6×250 mm,5μm)色谱柱,以0.05 moL.L-1磷酸二氢钾溶液(以氢氧化钠试液调pH7.0)-甲醇(40∶60)为流动相,检测波长为285nm,流速为1.0 mL.min-1,柱温为35℃。结果雷贝拉唑钠浓度在0.002~0.01g.L-1内有良好的线性关系,r=0.9999。平均回收率为99.64%,RSD=0.522%。检测限为1.52×10-8g.L-1。结论本法简便、准确,灵敏度高,适用于雷贝拉唑钠肠溶片的质量控制。 OBJECTIVE To establish an HPLC method for the determination of rabeprazole in Rabeprazole Sodium Enteric-coated Tablets and its related substances.METHODS A stable HPLC method was established on a ZORBAX SB-C18 column(4.6×250mm,5μm),the mobile phase consisted of 0.05mol·L-1 potassium dihydrogen phosphate,(adjusted PH7.0 with sodium hydroxide)-methanol(40∶60),the detection wavelength was 285nm,the flow rate was 1.0mL·min-1The column temperature was 35℃.RESULTS A good linear relationship was observed in the concentration range of 0.002~0.01g·L-1 with the correlation coefficient of 0.9999,the average recovery was 99.64%,RSD=0.522%.CONCLUSION The method was simple,accurate and sensitive,and it was suitable for the quality control of Rabeprazole Sodium Enteric-coated Tablets.
出处 《齐鲁药事》 2010年第8期472-474,共3页 qilu pharmaceutical affairs
关键词 高效液相色谱法 雷贝拉唑钠肠溶片 含量 有关物质 HPLC Rabeprazole Sodium Enteric-coated Tablets Determination Related substance
  • 相关文献

参考文献3

二级参考文献14

  • 1高志发.奥美拉唑致严重不良反应2例[J].中国医院药学杂志,2000,20(1):63-64. 被引量:10
  • 2Kovacs T O G,Sytnik B,Humphries T J,et al.Alow dose of a new proton inhibitor LY307640(E3810)effectively inhibits acid secretion in humans[J].Gastroenterology,1996,110:A161. 被引量:1
  • 3Swans K,Hoyumpa A M,Merritt G J.Review article:the pharmac-okinetics of rabeprazole in health and disease[J].Aliment Pharmacol Ther,1999,13(Suppl 3),11-17. 被引量:1
  • 4Langtry H D,Markham A.Rabeprazole:a review of its use in acid-related gastrointestinal disorders[J].Drugs,1999,58(4):725-742. 被引量:1
  • 5Williams M P,Pounder R E.Review article:the pharmacology of rabeprazole[J].Aliment Pharmacol Ther,1999,13(Suppl 3):3-10. 被引量:1
  • 6Blanshard C,Millson C,Sercombe J,et al.The effects of raberazole on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects[J].Gut,1996,39(Suppl 3):A47. 被引量:1
  • 7Dammann H G,Burkhardt F,Bell N E,et al.Raberazole effectively inhibits 24-hour H activity and nocturnal acid secretion in heahthy subjects[J].Gut,1996,39(Suppl 3):A47. 被引量:1
  • 8Caos A,Moskvitz M,Dayal Y,et al.Raberazole for the prevention of pathologic and tymptomatic relapse of erosive of ulcerative[J].Gastroenterol,2000,95(11):3081-3088. 被引量:1
  • 9Keane W F,Swan S K,Grimes I,et al.Rabeprazole:pharmacokinetics and tolerability in patients with stable,end-stagerenal failure[J].J Clin Pharmacol,1999,39(9):927-933. 被引量:1
  • 10Hongo M,Kimpara T,Moriyama S,et al.Effect of rabeprazole(E3810),a novel proton pump inhibitor,on intragastric pH in healthy volunteers[J].Tohoku J Exp Med,1998,186(1):43-50. 被引量:1

共引文献13

同被引文献29

引证文献8

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部